The Institute of Immunology, Inc. has a long-standing tradition in the manufacture of viral vaccines. Our own „know-how“ resulted in the development of the Edmonston-Zagreb vaccine strain which became available on the local market in 1968 as the authorised Measles Vaccine.
In the 1980-s, the Institute of Immunology qualified as a supplier of the Measles Vaccine for the UN. From then on, viral vaccines were distributed in different world markets proving to be safe and effective for millions of vaccinated children. According to WHO, active immunity which persists after vaccination with the Edmonston-Zagreb vaccine strain is better, according to WHO data, then after vaccination using other vaccine strains against measles (e.g. Schwarz).
The licence for production of the Measles Vaccine based on the Edmonston-Zagreb strain was sold to Switzerland, India and Mexico.